首页> 美国政府科技报告 >Administration of Additional Phosphorylated Prolactin During Pregnancy Inhibits Mammary Ductal Branching and Promotes Premare Lobuloalveolus Development
【24h】

Administration of Additional Phosphorylated Prolactin During Pregnancy Inhibits Mammary Ductal Branching and Promotes Premare Lobuloalveolus Development

机译:在妊娠期间施用额外的磷酸化催乳素抑制乳腺导管分支并促进早期的Lobuloalveolus发育

获取原文

摘要

Prolactin (PRL) is a hormone recognized as promoting both proliferation and differentiation in the mammary gland. Current theory proposes that it is the coexisting steroidal environment that dictates which of these two activities predominates. During the tenure of this grant, however, we have determined that the ratio of unmodified PRL (U-PRL) to phosphorylated PRL (as judged by the use of a molecular mimic, S179D PRL) is also important in this regard. Working directly on the mammary gland, U-PRL promotes proliferation, whereas S179D PRL inhibits proliferation and yet promotes differentiation.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号